[ad_1] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes COVID-19 (coronavirus disease 2019) has infected over 58.5 million people worldwide and killed over 1.38 million is one of the health crises most significant global in recent memory. There are currently no effective and safe vaccines to prevent SARS CoV-2 …
Read More »Hyperimmune anti-SARS-CoV-2 globulin produced from a convalescent plasma pool has 3 antibody neutralizing activities
[ad_1] The severe acute respiratory syndrome virus coronavirus 2 (SARS-CoV-2) emerged from Wuhan, China in late 2019 and rapidly spread around the world, progressing into a full-fledged pandemic. As this is a new virus, scientists around the world immediately began work on developing a vaccine or effective therapeutic agents to …
Read More »COVID-19 potentially has negative impacts on male fertility
[ad_1] A review recently posted on Journal of Medical Virology discussed some of the effects infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19), can have on male fertility. In the paper, Cemile Seymen of the Gazi University Institute of Health Sciences, …
Read More »Genetic variations of SARS-CoV-2 transmission in cats
[ad_1] Using cats as an animal model to study the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the researchers determined that the virus has a narrow transmission bottleneck. The current 2019 coronavirus (COVID-19) pandemic, caused by the agent SARS-CoV-2, is widely believed to be zoonotic in origin (meaning …
Read More »Optimizing SARS-COV-2 Inactivation for COVID-19 Research at Lower Biosafety Levels
[ad_1] Researchers at Montana State University have validated and compared two methods of inactivating the causative agent of coronavirus disease 2019 (COVID-19) that would allow studying the virus at a lower biosafety level (BSL) than is currently required. The risk posed to researchers by this highly infectious agent – severe …
Read More »Pod e-cigarettes are less harmful to health than traditional cigarettes
[ad_1] Reviewed by Emily Henderson, B.Sc.November 18, 2020 Cigarette smoking causes more than 480,000 deaths each year in the United States, according to federal government data, and some smokers find it nearly impossible to quit. Many of these smokers use regular or combustible cigarettes. Doctors and scientists have been exploring …
Read More »How weather affects SARS-CoV-2 transmission: a US-based case study
[ad_1] How weather changes affect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the subject of several studies. Researchers’ concern about this aspect of the 2019 coronavirus (COVID-19) pandemic stems from observations that the flu virus and other coronaviruses follow seasonal patterns. Understanding how SARS-CoV-2 transmissibility is affected by …
Read More »E-cigarette users have an increased susceptibility to the flu, COVID-19
[ad_1] Reviewed by Emily Henderson, B.Sc.November 18, 2020 In a controlled study of smokers, non-smokers, and e-cigarette users, researchers at the University of North Carolina School of Medicine found that e-cigarette users exhibited significantly altered immune responses to a influenza virus infection pattern, suggesting a increased susceptibility to the disease. …
Read More »Chilblains-like skin lesions reported in adolescents and young adults during the pandemic
[ad_1] As the coronavirus disease (COVID-19) pandemic grows, more manifestations of viral infection emerge. Early in the pandemic, people with COVID-19 reported symptoms of fever, cough, and difficulty breathing. Later, other symptoms were added, such as loss of taste, loss of smell, and mouth injuries in children. A team of …
Read More »Natural products and herbal medicines show promise in the fight against COVID-19
[ad_1] Researchers in China and the United States have called for further research on the potential prophylactic effects of natural products and herbal medicines on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and subsequent coronavirus disease. 2019 (COVID-19). In an article recently published in the journal Frontiers in pharmacology, …
Read More »